@targetedonc.bsky.social
@targetedonc.bsky.social"We're developing a RAS toolkit, not just one RAS drug....all of which are going to have some use in some combination with one another." - Benjamin Herzberg, MD, @columbiacancer.bsky.social Listen to the new episode of Targeted Talks: www.targetedonc.com/view/herzber...
@targetedonc.bsky.socialICYMI 🔎: An #FDA advisory panel has backed the Galleri MCED test for adults 50+, citing strong specificity, mixed sensitivity, and follow-up impacts as FDA weighs approval.
Read more about the decision: targetedonc.com/view/fda-pan...
@targetedonc.bsky.socialHans Lee, MD, @scri.com, talks about the new IMS/IMWG consensus on cure in myeloma from #IMS26 www.targetedonc.com/view/hans-le...
@targetedonc.bsky.social🚨 Conference update: Catch up with the final day of #IMS26 highlights www.targetedonc.com/view/ims-202...
@targetedonc.bsky.social📢 ICYMI: The #FDA has approved lirafugratinib (Lyrfigtu) for adults with previously treated unresectable, locally advanced or metastatic #cholangiocarcinoma harboring an FGFR2 gene fusion or other rearrangement.
Read more: targetedonc.com/view/fda-app...
@targetedonc.bsky.socialWe've recapped days 1 and 2 of #IMS26 @myeloma-society.bsky.social. Stay tuned for day 3!
Day 1: www.targetedonc.com/view/ims-202...
Day 2: www.targetedonc.com/view/ims-day...
@targetedonc.bsky.socialExcited for day 2 at #IMS26!
@targetedonc.bsky.socialFrom a presentation by Stefan Knop, MD: On-body injectors are preferred by both patients and HCPs, moving myeloma drug administration to a “fill, click, stick” model
@targetedonc.bsky.socialThe definition also requires: • At least 4 MRD tests must be negative, including one at the five-year mark, with no positive result in between. • The tests must use NGS/NGF sensitive enough to detect 1 myeloma cell in 1 million cells • Advanced imaging must show no disease
@targetedonc.bsky.socialAccording to the new consesus, a patient with newly diagnosed or relapsed myeloma may be considered cured after 5 years in complete remission after treatment ends.
@targetedonc.bsky.social“Cure” requires convergence of statistical and biological domains
@targetedonc.bsky.socialGoals of the IMWG/IMS meeting: identify the proportion of patients who can be cured and define a rigorous guideline of what cure can be
@targetedonc.bsky.socialExcited to hear @nikhilmunshi.bsky.social discuss the concept of cure in myeloma! #IMS2026
@targetedonc.bsky.socialWe've landed in Glasgow and are ready for day 1 of #IMS26! Stay tuned this week for updates, interviews, and more from our team on the ground!
